Signadori Bio Raises €11 Million Seed Round to Advance Next-Generation Solid Tumour Platform

AI Briefing

• – Signadori Bio raises €11 million in seed funding to advance its solid tumour platform.
• – The investment was led by Taiho Ventures, with participation from existing investors Sofinnova Partners and Invivo Partners.
• – The raise brings the total funding to €11.1 million.